12 latest endocrinology guidelines/consensus, included in one article October guideline update

This article summarizes the recently released guidelines/consensus on endocrinology diseases at home and abroad for teachers to refer to and download
.

Guidelines for Nutritional Treatment of Diabetes Medicine in China (2022 Edition)

Medical nutrition therapy (MNT) is the foundation of comprehensive diabetes treatment and is an indispensable measure
for prevention and control at any stage of the course of diabetes.
In 2010, the Nutrition Physician Professional Committee of the Chinese Medical Doctor Association and the Diabetes Branch of the Chinese Medical Association jointly formulated China's first MNT guidelines for diabetes and updated
them in 2015.

In the past 7 years, many breakthroughs have been made in the field of diabetes MNT and metabolic therapy, organized by the Nutrition and Metabolic Management Branch of the China Association for the Promotion of International Exchange of Healthcare, experts from the Clinical Nutrition Branch of the Chinese Nutrition Society, the Diabetes Branch of the Chinese Medical Association, the Parenteral Enteral Nutrition Branch and the Nutrition Physician Professional Committee of the Chinese Medical Doctor Association have launched the revision of the "Chinese Guidelines for Nutritional Treatment of Diabetes Medicine (2013)", involving diabetes nutrition prevention, treatment, complication prevention, Artificial sweeteners and new phytochemicals, parenteral enteral nutrition support and many other fields
.
In the process of formulating the guidelines, in strict accordance with the requirements of methodology, with reference to the requirements of the "Guidelines for the Formulation/Revision of Clinical Diagnosis and Treatment Guidelines in China (2022 Edition)", adhering to the purpose of being problem-oriented, paying equal attention to evidence level and recommendation, and serving the clinic, combined with Chinese clinical practice to raise questions and collect evidence, the "Chinese Guidelines for Nutritional Treatment of Diabetes Medicine (2022 Edition)" was formed, aiming to guide and standardize clinical MNT
.

Literature link: https://guide.
medlive.
cn/guideline/26833

Guidelines for the diagnosis and treatment of hyperthyroidism and other causes of thyrotoxicosis in China

Hyperthyroidism (hyperthyroidism) is a common disease of the endocrine system, and in order to standardize the clinical diagnosis and treatment of hyperthyroidism in China, five societies have jointly formulated this guideline
.
Based on the scientific evidence in this field and the experience of clinicians, the guidelines have formulated 107 recommendations, covering the identification of the causes of thyrotoxicosis, the diagnosis of Graves disease and the selection of treatment options, the personalized management of hyperthyroidism in special populations such as juvenile hyperthyroidism, hyperthyroidism during pregnancy, elderly hyperthyroidism, special types of hyperthyroidism such as Graves ophthalmopathy, subclinical hyperthyroidism, thyroid storm, drug-induced hyperthyroidism, etc.
, the guidelines are applicable to internal medicine, surgery, nuclear medicine, etc.
Doctors
in general medicine and other departments.

Literature link: https://guide.
medlive.
cn/guideline/26625

Chinese Expert Consensus on Risk Assessment and Management of Panvascular Disease in Patients with Type 2 Diabetes (2022 Edition)

Panvascular disease is not only a common comorbidity of type 2 diabetes mellitus (T2DM), but also the leading cause of
disability and death in patients with T2DM.
In order to promote multidisciplinary cooperation and interdisciplinary integration and early detection of panvascular disease in patients with T2DM, the Cardiovascular Medicine Branch of the Chinese Medical Doctor Association took the lead in organizing domestic experts in the fields of cardiovascular disease, endocrinology, nephrology, neurology and health management, sorted out the latest evidence-based medical evidence and important progress in related disciplines at home and abroad, and formulated this consensus
.

The consensus covers the epidemiological characteristics, pathophysiological mechanism, multidisciplinary collaborative diagnosis and treatment, risk assessment and management of panvascular disease in T2DM patients, highlights the early risk assessment of panvascular disease in T2DM patients (risk factors, vascular structure and function, and target organ damage assessment at least once a year), emphasizes that the management of panvascular disease in T2DM patients needs to be jointly participated by patients and multidisciplinary physicians, and strengthens the control of blood glucose, blood pressure, blood lipid control and antiplatelet therapy on the basis of lifestyle intervention
。 This consensus will help guide and help clinicians to standardize and comprehensively manage panvascular disease in patients with T2DM and improve patient outcomes
.

Literature link: https://guide.
medlive.
cn/guideline/27021

2022 KDIGO Clinical Practice Guidelines: Diabetes management in patients with chronic kidney disease

Recently, the "KDIGO Clinical Practice Guidelines 2022: Diabetes Management in Patients with Chronic Kidney Disease", written by experts from the Global Organization for Improving Kidney Disease Prognosis (KDIGO), was published in the journal Kidney International, which is an update
to the 2020 edition.

The guidelines summarize the previous clinical evidence-based medical evidence, especially the high-quality evidence on the protection of target organs of diabetic patients with new hypoglycemic drugs in recent years, and give clinicians recommendations or suggestions
for scientific management of patients with diabetes and chronic kidney disease from the aspects of blood glucose level control, lifestyle intervention and selection of hypoglycemic drugs.

Literature link: https://guide.
medlive.
cn/guideline/27062

2022 AGA Clinical Practice Guidelines: pharmacological interventions in obese adults

Recently, the "AGA Clinical Practice Guidelines on Pharmacological Interventions for Adults With Obesity" written by experts from the American Gastroenterology Association was released in the academic journal Gastroenterology, providing clinical guidance for the drug treatment of adult obesity.
A total of nine recommendations
were made.

Literature link: https://guide.
medlive.
cn/guideline/27056

2022 ISPAD clinical practice guidelines: diabetic ketoacidosis and hyperglycemic hyperosmolar state

In October 2022, the International Association of Children and Adolescents Diabetes (ISPAD) published guidelines
for the management of diabetic ketoacidosis and hyperglycemic hyperosmolar states.
The main topics cover pathophysiology, the definition of diabetic ketoacidosis, treatment, clinical and biochemical monitoring, prevention of complications, recurrence, and management
of diabetic hyperosmolar states.

Literature link: https://guide.
medlive.
cn/guideline/27025

2022 ISPAD Clinical Practice Guidelines: Adolescent Diabetes

In October 2022, the International Association of Children and Adolescents Diabetes (ISPAD) released guidelines
for adolescent diabetes.
Adolescence is a transitional stage of development between childhood and adulthood, during which endocrine changes directly affect glycemic control
in diabetes.
This article provides guidance and recommendations
for adolescent diabetes.

Links to literature: https://guide.
medlive.
cn/guideline/27012

2022 EASD/ADA Consensus Report: Automated Insulin Dosing – Benefits, Challenges and Recommendations

In October 2022, the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) jointly published a consensus report
on automatic insulin administration – benefits, challenges and recommendations.
In the past few years, the first automated insulin delivery (AID) system has received regulatory approval
.
This paper briefly summarizes the advantages, limitations and challenges of current AID systems and presents a series of consensus recommendations to further strengthen and improve the safe use of
these systems.

Literature link: https://guide.
medlive.
cn/guideline/26912

2022 AACE Clinical Practice Guidelines: Comprehensive Treatment Plan for Diabetes (Updated)

In October 2022, the American College of Clinical Endocrinologists' Clinical Practice Guidelines: Comprehensive Treatment Plan for Diabetes (2022) was published in the journal Endocrine Practice, an update
to the 2015 edition.

The main content covers diabetes screening, diagnosis, blood glucose targeting, blood glucose monitoring, management of diabetes comorbidities and complications, prediabetes, treatment of type 1 and type 2 diabetes, and patient education, and puts forward a total of 170 practical recommendations
.

Literature link: https://guide.
medlive.
cn/guideline/26989

2022 ETA guidelines: Management of thyroid nodules and differentiated thyroid cancer in children

In October 2022, the European Thyroid Association (ETA) published guidelines
for the management of thyroid nodules and differentiated thyroid cancer in children.
Differences in the clinical, molecular, and pathologic features of pediatric and adult thyroid cancer underscore the need for specific management recommendations for the
paediatric population.
This article provides guidance and recommendations for the diagnosis, treatment and follow-up of the management of thyroid nodules and differentiated thyroid cancer in children
.

Literature link: https://guide.
medlive.
cn/guideline/26984

2022 Consensus Recommendation: Automated Insulin Delivery (AID) Technology in Clinical Practice

Although near-normal blood sugar levels have been shown to prevent or delay the progression of long-term complications of diabetes, a significant proportion of people with diabetes do not meet their blood sugar targets
.
Automated insulin delivery (AID) technology has made great progress in the past few years, and this article focuses on providing consensus recommendations
for the use of AID technology in clinical practice.

Literature link: https://guide.
medlive.
cn/guideline/26708

2022 Consensus Statement: About the Elderly Population and Vitamin D

This consensus summarizes the results of the 5th International Conference on the Vitamin D Controversy, on the theme of Vitamin D and Aging
.

The consensus states that the body's ability to produce vitamin D decreases with age, but aging skin can still produce enough vitamin D
when exposed to ultraviolet light.
Vitamin D supplementation should be combined with calcium to reduce the risk
of fracture in older adults.
The goal of adequate vitamin D status should be 25(OH)D>50 nmol/l
.
A daily low-dose regimen of vitamin D reduces the risk of falls compared with the occasional high-dose dose, especially in
older people.
Of the three possible strategies for getting vitamin D — sun exposure, foods, and supplements — the latter appears to be the most effective and practical
.

Literature link: https://guide.
medlive.
cn/guideline/27108